Asthma Treatment and Management
86 Questions
0 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

What is the primary goal when stepping down asthma controller treatment?

  • To switch to a different medication class
  • To increase patient autonomy in adjusting medication doses
  • To rapidly reduce medication costs
  • To find the lowest dose that controls symptoms and exacerbations, and minimizes the risk of side-effects (correct)
  • When considering stepping down asthma controller treatment, what should be recorded?

  • Only the patient's medication regimen
  • Only symptom control levels
  • Only lung function measurements
  • The level of symptom control and risk factors (correct)
  • What is recommended for patients with ≥1 exacerbations in the previous year?

  • Low-dose ICS/formoterol maintenance and reliever regimen (correct)
  • Tiotropium add-on therapy
  • High-dose ICS monotherapy
  • Adrenaline injection only
  • According to the guidelines, what should be avoided in patients with severe asthma?

    <p>Tobacco smoke exposure</p> Signup and view all the answers

    What is the recommended approach to stepping down ICS doses?

    <p>Reduce by 25–50% every 3 months</p> Signup and view all the answers

    What is an important component of guided asthma self-management?

    <p>Self-monitoring of symptoms and/or PEF, a written asthma action plan, and regular medical review</p> Signup and view all the answers

    What should be referred to a specialist center, if available, for consideration of add-on medications and/or sputum-guided treatment?

    <p>Patients with severe asthma</p> Signup and view all the answers

    What is recommended for patients with confirmed food allergy?

    <p>Appropriate food avoidance and ensure availability of injectable epinephrine for anaphylaxis</p> Signup and view all the answers

    What is a non-pharmacological intervention for asthma management?

    <p>Avoidance of tobacco smoke exposure</p> Signup and view all the answers

    What is discouraged in adults with asthma due to the risk of exacerbations?

    <p>Stopping ICS</p> Signup and view all the answers

    What is an essential aspect of the stepwise approach to control asthma symptoms and reduce risk?

    <p>Inhaler technique assessment</p> Signup and view all the answers

    What is the primary goal of a step-up therapy in asthma management?

    <p>To reduce the frequency of exacerbations</p> Signup and view all the answers

    Which of the following is a non-pharmacological strategy for asthma management?

    <p>Treat modifiable risk factors</p> Signup and view all the answers

    What is an important consideration when developing an asthma action plan?

    <p>Patient's inhaler technique and adherence</p> Signup and view all the answers

    What is a potential systemic side-effect of inhaled corticosteroids (ICS) in asthma management?

    <p>Oropharyngeal candidiasis</p> Signup and view all the answers

    When is a step-down therapy considered in asthma management?

    <p>When lung function improves</p> Signup and view all the answers

    What is the preferred controller choice in the stepwise approach to asthma management?

    <p>Inhaled corticosteroids</p> Signup and view all the answers

    Which of the following is a factor to consider when adjusting ICS dosing in asthma management?

    <p>Patient's symptom severity</p> Signup and view all the answers

    What is an essential aspect of patient education in the stepwise approach to asthma management?

    <p>Inhaler technique demonstration</p> Signup and view all the answers

    What is the primary goal of assessing lung function in asthma management?

    <p>To monitor treatment efficacy</p> Signup and view all the answers

    What is the first step to consider when thinking about stepping up asthma treatment?

    <p>Check for correct inhaler technique</p> Signup and view all the answers

    In which patients with allergic rhinitis is adding SLIT considered?

    <p>Adult patients with exacerbations despite ICS treatment and FEV1 &gt; 70% predicted</p> Signup and view all the answers

    What is the recommended approach when symptoms are controlled for 3 months?

    <p>Step down asthma treatment</p> Signup and view all the answers

    What should be advised about non-pharmacological therapies?

    <p>Advise about physical activity, weight loss, and avoidance of sensitizers</p> Signup and view all the answers

    What should be treated in asthma management?

    <p>Comorbidities and modifiable risk factors</p> Signup and view all the answers

    What should be checked before stepping up asthma treatment?

    <p>Diagnosis and inhaler technique</p> Signup and view all the answers

    If a patient's symptoms are not typical of asthma, what should be done next?

    <p>Further history and tests for alternative diagnoses</p> Signup and view all the answers

    What is the next step if the results of spirometry/PEF with reversibility test support asthma diagnosis?

    <p>Confirm asthma diagnosis</p> Signup and view all the answers

    What is the primary goal of the initial evaluation in asthma diagnosis?

    <p>To rule out alternative diagnoses</p> Signup and view all the answers

    When is a detailed history/examination for asthma warranted?

    <p>When symptoms are typical of asthma</p> Signup and view all the answers

    What is the purpose of further history and tests for alternative diagnoses?

    <p>To rule out alternative diagnoses</p> Signup and view all the answers

    When can a patient's symptoms be considered controlled?

    <p>When symptoms are under control for 3 months</p> Signup and view all the answers

    What is the next step if the results of spirometry/PEF with reversibility test do not support asthma diagnosis?

    <p>Arrange other tests</p> Signup and view all the answers

    What is the main goal of the initial evaluation in asthma diagnosis?

    <p>To rule out alternative diagnoses</p> Signup and view all the answers

    What is the primary goal when assessing a patient's cough?

    <p>To determine the underlying cause of the cough</p> Signup and view all the answers

    Which of the following is a geriatric specific consideration in pulmonary disease management?

    <p>Cerumen impaction</p> Signup and view all the answers

    What is a common complaint associated with pulmonary disease?

    <p>Dyspnea</p> Signup and view all the answers

    Which of the following is a differential diagnosis for cough?

    <p>All of the above</p> Signup and view all the answers

    What is a characteristic of a productive cough?

    <p>It produces mucus or phlegm</p> Signup and view all the answers

    What is a major player in pulmonary disease management?

    <p>Asthma</p> Signup and view all the answers

    What is the primary reason for checking adherence to asthma medications?

    <p>To reduce the risk of uncontrolled asthma symptoms and exacerbations</p> Signup and view all the answers

    What is the estimated percentage of adults and children who do not take controller medications as prescribed?

    <p>50%</p> Signup and view all the answers

    What is a recommended approach to identify patients with low adherence to asthma medications?

    <p>Ask an empathic question about adherence</p> Signup and view all the answers

    What is a common factor contributing to poor adherence to asthma medications?

    <p>All of the above</p> Signup and view all the answers

    What is the recommended approach to improve inhaler technique?

    <p>Demonstrate the correct technique</p> Signup and view all the answers

    How often should inhaler technique be re-checked?

    <p>Every 4-6 weeks</p> Signup and view all the answers

    What is the benefit of brief inhaler technique training?

    <p>Improved asthma control</p> Signup and view all the answers

    What should be avoided when prescribing ICS by pMDI?

    <p>Using multiple different inhaler types</p> Signup and view all the answers

    What is the main difference between atypical pneumonia and pneumococcal pneumonia?

    <p>Atypical pneumonia is more common in persons under 40 years old</p> Signup and view all the answers

    What is the indication for pulse oximetry screening in community-acquired pneumonia (CAP)?

    <p>Suspect pneumonia</p> Signup and view all the answers

    What is the recommended duration of therapy for community-acquired pneumonia (CAP) in severe cases?

    <p>10-14 days</p> Signup and view all the answers

    What is the most common cause of chronic cough?

    <p>Postnasal drip</p> Signup and view all the answers

    What is the definition of chronic bronchitis?

    <p>Cough and sputum production for at least 3 months in 2 consecutive years</p> Signup and view all the answers

    What is the diagnostic test of choice for obstructive sleep apnea (OSA)?

    <p>Polysomnogram (PSG)</p> Signup and view all the answers

    What is a consequence of untreated obstructive sleep apnea (OSA)?

    <p>All of the above</p> Signup and view all the answers

    What is the recommended approach to managing chronic cough in geriatric patients?

    <p>All of the above</p> Signup and view all the answers

    What is a common misperception about older people with respiratory symptoms?

    <p>They tend to overestimate their symptoms</p> Signup and view all the answers

    What is the recommended approach to diagnosing and treating rhinosinusitis in geriatric patients?

    <p>The same approach as in younger patients</p> Signup and view all the answers

    What is the frequency of night time symptoms that may indicate the need for an ICS as a controller?

    <p>More than twice a month</p> Signup and view all the answers

    What is the primary consideration when choosing between treatment options at a population level?

    <p>Cost and availability at the population level</p> Signup and view all the answers

    In individual patient decisions, what is an important consideration when discussing treatment options?

    <p>Patient characteristics and phenotype</p> Signup and view all the answers

    What is the frequency of cannister use of a rescue medication that may indicate the need for an ICS as a controller?

    <p>More than two cannisters in a year</p> Signup and view all the answers

    What is an important consideration when choosing between controller options for an individual patient?

    <p>All of the above</p> Signup and view all the answers

    What is the basis for the 'preferred treatment' at each step in the guidelines?

    <p>Efficacy and effectiveness based on group mean data</p> Signup and view all the answers

    Why is it important to consider the patient's phenotype when choosing between controller options?

    <p>Because it affects the patient's response to treatment</p> Signup and view all the answers

    What is the primary goal of considering the patient's goals and concerns for their asthma?

    <p>To improve patient engagement and adherence</p> Signup and view all the answers

    What is the estimated percentage of people ≥65 years who meet the criteria for asthma?

    <p>5%-10%</p> Signup and view all the answers

    What is the primary cause of wheezing in 'cardiac asthma'?

    <p>Heart failure</p> Signup and view all the answers

    What is the median survival time for patients with idiopathic pulmonary fibrosis?

    <p>3-5 years</p> Signup and view all the answers

    What is the recommended approach for treating sleep apnea?

    <p>All of the above</p> Signup and view all the answers

    What is the leading cause of death in older adults with COPD?

    <p>COPD itself</p> Signup and view all the answers

    What is the primary benefit of smoking cessation in older adults with COPD?

    <p>Slowing down the decline in lung function</p> Signup and view all the answers

    What is the estimated number of people affected by asthma worldwide?

    <p>300 million</p> Signup and view all the answers

    What is a common complication of obstructive sleep apnea?

    <p>All of the above</p> Signup and view all the answers

    What is the primary goal of asthma management in older adults?

    <p>Prevention of exacerbations</p> Signup and view all the answers

    What is a characteristic of idiopathic pulmonary fibrosis?

    <p>Clubbing is often a prominent finding</p> Signup and view all the answers

    What is the main difference between the symptoms of Mycoplasma pneumoniae and Streptococcus pneumoniae in older adults?

    <p>Mycoplasma pneumoniae presents with a more subtle onset of symptoms, while Streptococcus pneumoniae presents with a more sudden onset of symptoms</p> Signup and view all the answers

    What is the recommended approach to the management of chronic cough in older adults?

    <p>Empiric treatment for GERD, asthma, and postnasal drip, and then re-evaluate</p> Signup and view all the answers

    What is the primary goal of the CURB-65 mortality prediction tool in patients with community-acquired pneumonia (CAP)?

    <p>To predict the risk of mortality</p> Signup and view all the answers

    What is the recommended approach to the management of obstructive sleep apnea (OSA) in older adults?

    <p>Avoidance of alcohol, sedatives, and hypnotics, and weight loss, in addition to positive airway pressure (PAP) therapy</p> Signup and view all the answers

    What is the primary difference between the management of community-acquired pneumonia (CAP) in inpatients and outpatients?

    <p>The use of antibiotics with a broader spectrum of activity in inpatients</p> Signup and view all the answers

    What is the recommended approach to the evaluation of a single pulmonary nodule in an older adult?

    <p>Review of previous imaging studies, and then follow-up with serial imaging studies</p> Signup and view all the answers

    What is the primary goal of the diagnostic approach to chronic cough in older adults?

    <p>To identify the underlying cause of the cough, and then develop an empiric treatment plan</p> Signup and view all the answers

    What is the recommended approach to the management of wheezing in older adults?

    <p>Empiric treatment for asthma, and then re-evaluate</p> Signup and view all the answers

    What is the primary difference between the management of community-acquired pneumonia (CAP) in younger adults and older adults?

    <p>The consideration of age-related changes in lung function and underlying co-morbidities in older adults</p> Signup and view all the answers

    What is the primary goal of the follow-up evaluation in patients with community-acquired pneumonia (CAP)?

    <p>To evaluate the response to treatment, and then adjust the treatment plan as necessary</p> Signup and view all the answers

    Study Notes

    Initiating Asthma Treatment

    • May be initiated by a patient with a written asthma action plan
    • Day-to-day adjustment for patients prescribed low-dose ICS/formoterol maintenance and reliever regimen

    Stepping Down Asthma Treatment

    • Consider stepping down after good control maintained for 3 months
    • Aim to find each patient's minimum effective dose that controls symptoms and exacerbations
    • Stepping down ICS doses by 25-50% at 3-month intervals is feasible and safe for most patients
    • Stopping ICS is not recommended in adults with asthma due to the risk of exacerbations

    General Principles for Stepping Down

    • Aim to find the lowest dose that controls symptoms and exacerbations, and minimizes the risk of side-effects
    • Consider stepping down when symptoms have been well controlled and lung function stable for ≥3 months
    • Prepare for step-down by recording symptom control, considering risk factors, and booking a follow-up visit

    Treating Modifiable Risk Factors

    • Provide skills and support for guided asthma self-management
    • Prescribe medications or regimens that minimize exacerbations, such as ICS-containing controller medications
    • Encourage avoidance of tobacco smoke and provide smoking cessation advice and resources
    • For patients with severe asthma, refer to a specialist center for consideration of add-on medications and/or sputum-guided treatment
    • For patients with confirmed food allergy, ensure appropriate food avoidance and availability of injectable epinephrine for anaphylaxis

    Non-pharmacological Interventions

    • Avoidance of tobacco smoke exposure is crucial, provide advice and resources at every visit
    • Encourage physical activity due to its general health benefits

    Stepwise Approach to Control Asthma Symptoms and Reduce Risk

    • Diagnosis, symptom control, and risk factors should be considered
    • Inhaler technique and adherence, patient preference, and lung function should be evaluated
    • Non-pharmacological strategies and treatment of modifiable risk factors are essential
    • Referral for add-on treatment and consideration of stepping up or down should be considered based on patient response

    Pulmonary Disease Management

    • Pulmonary disease management involves understanding common complaints, geriatric specific considerations, and the major players in the disease.

    Common Complaints

    • Cough is a common complaint, with differential diagnoses including prescription drugs, cerumen impaction, post nasal drip, COPD, asthma, postinfection, GERD, and occupational or environmental factors.
    • Dyspnea is a common complaint, with underlying causes to be identified.
    • Hemoptysis is a common complaint, with underlying causes to be identified.

    Cough

    • A thorough history is necessary to diagnose the cause of a cough, including:
      • When did it begin?
      • When does it occur?
      • What stimulates it/aggravates it?
      • What makes it better?
      • Describe the quality (productive or nonproductive?)
    • Cough can be a symptom of various conditions, including URIs, acute and chronic bronchitis, pneumonia, single pulmonary nodule, and obstructive sleep apnea.

    The Major Players

    • Asthma is a major player in pulmonary disease management.

    • COPD is a major player in pulmonary disease management.### Pneumonia

    • Common causes of pneumonia: Influenzae, Moraxella catarrhalis, Staph aureus, Anaerobes, Group A strep, Immunocompromised—CMV or PCP, M.catarrhalis

    • Pneumococcal pneumonia: S pneumoniae (gram +), abrupt onset, productive cough with rusty colored sputum, fever, chills, pleuritic chest pain, more subtle in older patients

    • Atypical pneumonia: Mycoplasma pneumoniae, headache, sore throat, myalgia, dry hacking cough, most common in persons under 40, may be clinically indistinguishable from pneumococcal pneumonia

    Differences in Presentation

    • Mycoplasma pneumonia: sore throat, fever, dry hacking cough, complications include sinusitis, OM, erythema multiforme, intravascular hemolysis, meningoencephalitis, toxic psychosis, myocarditis or pericarditis
    • Chlamydia pneumonia: biphasic illness, younger individuals, severe pharyngitis and laryngitis, fever, cough

    Physical Exam

    • No specific signs can confirm pneumonia
    • PE cannot reliably distinguish type of pneumonia
    • Tachypnea is more common in older adults
    • Pulse oximetry screening should be performed if suspect CAP
    • Fever, increased tactile fremitus, dullness to percussion, egophony, crackles (rales), bronchial breath sounds

    Diagnostic Testing

    • CXR required to differentiate
    • Normal CXR does not exclude diagnosis
    • Pulse ox, CBC with diff, electrolytes, rapid test for influenza may be helpful
    • Additional testing is indicated in those severely ill, those immunosuppressed, and those HIV+

    CAP Ambulatory Treatment

    • Hydration, respiratory hygiene, ASA or acetaminophen for fever & HA, smoking cessation, prevention—pneumococcal & influenza vaccine
    • Empiric treatments: azithromycin, clarithromycin, doxycycline, levofloxacin, moxifloxacin, beta-lactam, combination of beta-lactam and macrolide

    CAP Inpatient Treatment

    • Combination of beta-lactam and macrolide, or fluoroquinolone
    • ICU: combination of beta-lactam and macrolide or fluoroquinolone
    • Duration of therapy: minimum 5 days, should be afebrile for 48-72 hours, stable BP, adequate oral intake, and room air O2 sat >90%

    Mortality Prediction Tool

    • CURB-65: confusion, urea, respiratory rate, blood pressure, age > 65

    Follow-up

    • Telephone follow-up in 24 hours
    • Office visit in 3-4 days
    • Reassure cough and fatigue may last 3-4 weeks
    • Repeat CXR in 2 weeks for young adults, 4-6 weeks for smokers and older adults, 8 weeks for frail elderly

    Chronic Cough

    • Subacute cough: lasting 3-8 weeks
    • Chronic cough: persisting beyond 8 weeks
    • Most common causes: postnasal drip, GERD, asthma
    • Differential diagnoses: cigarette smoking, postnasal drip, allergies, chronic sinusitis, bronchospasm, CHF, impacted cerumen or other foreign body, bronchogenic tumors, chronic pulmonary infections, hematological, inflammation, psychogenic

    Bronchiectasis

    • Chronic cough, overproduction of secretions, reduced clearance of secretions
    • Excess airway secretions, chronic pulmonary infections, bronchogenic tumors, chronic aspiration

    Sleep Apnea

    • Pause in breathing for 10-90 seconds
    • Central apneas: absent airflow and respiratory efforts, neurological diseases
    • Obstructive apneas: tongue and soft palate fall backward, mixed apneas
    • Consequences: pulmonary HTN, HTN with LV dysfunction, cardiac dysrhythmias, psychomotor defects, hypoxia and hypercapnia

    Management

    • General measures: avoidance of alcohol, sedatives, hypnotics, weight loss, O2 therapy, nasal dilators
    • Specific measures: position therapy, positive airway pressure, oral appliances, surgical management

    Geriatric Specific Considerations

    • Age-related pulmonary changes: reduced airway size, shallow alveolar sacs, decline in chest wall compliance, intercostal muscle atrophy, reduction in diaphragmatic strength
    • Difficulties in recognizing respiratory symptoms: older people tend to underreport or underestimate respiratory symptoms
    • Multiple causes of respiratory problems: asthma, COPD, heart failure, GERD
    • Rhinosinusitis: treat bacterial rhinosinusitis with analgesics, saline irrigation, and antibiotics, treat chronic rhinosinusitis with topical nasal steroids and saline irrigation
    • Dyspnea: common causes include COPD, cardiac disease, asthma, interstitial lung disease, deconditioning
    • Wheezing: most common causes are asthma, COPD, heart failure### Indicators for ICS as a Controller
    • Symptoms more than twice a day
    • Night time symptoms more than twice a month
    • Severe asthma requiring emergency treatment or oral steroids more than twice a year
    • Use of more than two cannisters of rescue medication in a year

    Choosing Controller Options

    Population-Level Decisions

    • Based on efficacy, effectiveness, safety, availability, and cost at the population level
    • Considerations include:
      • Group mean data for symptoms
      • Exacerbations and lung function (from RCTs, pragmatic studies, and observational data)

    Individual Patient Decisions

    • Use shared decision-making with the patient/parent/carer to discuss:
      • Preferred treatment for symptom control and risk reduction
      • Patient characteristics (phenotype)
      • Patient preference
      • Medication options, considering factors such as arthritis, patient skills, and cost
    • Consider using a spacer for ICS by pMDI and avoiding multiple different inhaler types if possible

    Inhaler Technique

    • Check technique at every opportunity
    • Identify errors with a device-specific checklist
    • Correct technique with a physical demonstration and re-check up to 2-3 times
    • Re-check inhaler technique frequently, as errors often recur within 4-6 weeks
    • Confirm correct technique for prescribed inhalers

    Adherence to Asthma Medications

    • Poor adherence is very common (estimated 50% of adults and children)
    • Contributes to uncontrolled asthma symptoms and risk of exacerbations and asthma-related death
    • Contributory factors include:
      • Unintentional (e.g. forgetfulness, cost, confusion)
      • Intentional (e.g. no perceived need, fear of side-effects, cultural issues, cost)
    • Identify patients with low adherence by asking empathic questions

    Pulmonary Disease Management

    • Pulmonary disease management is a critical aspect of healthcare, particularly in geriatric populations.

    Common Complaints

    • Cough
    • Dyspnea
    • Hemoptysis
    • URIs
    • Acute and Chronic Bronchitis
    • Pneumonia
    • Single Pulmonary Nodule
    • Obstructive Sleep Apnea

    Cough

    • Begin with a thorough history
    • Important factors to consider:
      • When did it begin?
      • When does it occur?
      • What stimulates it/aggravates it?
      • What makes it better?
      • Describe the quality
      • Productive or nonproductive?

    Community Acquired Pneumonia (CAP)

    • Infection of the lung not acquired in the hospital, LTC, or other recent contact with a healthcare system
    • Evidence of consolidation on CXR
    • Treatment Guidelines from IDS/ATS
    • Management of CAP in older adults from TAID

    Etiology

    • Healthy: Strep pneumoniae, Mycoplasma pneumoniae, Chlamydophila pneumoniae, H influenzae, etc.
    • Elderly nursing home residents: Nosocomial gram negatives
    • Immunocompromised: CMV or PCP

    Pneumococcal Pneumonia Clinical Features

    • S pneumoniae (gram +)
    • Abrupt onset
    • Productive cough—rusty colored sputum
    • Fever, chills
    • Pleuritic chest pain
    • More subtle in older patients—could present with altered mental status or weakness

    Atypical Pneumonia Clinical Features

    • Mycoplasma pneumoniae main organism
    • Headache, sore throat
    • Myalgia
    • Dry hacking cough
    • Pathogens “atypical” as will not gram stain due to no cell wall
    • Most common in persons under aged 40

    Differences in Presentation

    • Mycoplasma Pneumonia: Sore throat, fever, dry hacking cough
    • Complications: Sinusitis, OM, erythema multiforme or erythema nodosum, intravascular hemolysis, meningoencephalitis, toxic psychosis, myocarditis or pericarditis
    • Persistent hacking cough for up to 6 weeks
    • Relapse occurs in 10 percent
    • Chlamydia Pneumonia: Biphasic illness
    • Younger individuals
    • Severe pharyngitis and laryngitis
    • Fever
    • Cough

    Physical Exam

    • No specific signs can confirm pneumonia
    • PE cannot reliably distinguish type of pneumonia
    • Tachypnea—more common in older adults
    • Pulse oximetry screening should be performed if suspect CAP
    • Fever
    • Increased tactile fremitus, dullness to percussion, egophony
    • Crackles (rales)
    • Bronchial breath sounds

    Diagnostic Testing

    • CXR required to differentiate
    • Normal CXR does not exclude diagnosis
    • Pulse Ox
    • CBC with diff
    • Electrolytes
    • Rapid test for influenza may be helpful
    • Additional testing is indicated in those severely ill, those immunosuppressed, and those HIV+

    CAP Ambulatory Treatment

    • Hydration
    • Respiratory hygiene
    • ASA or acetaminophen for fever & HA
    • Smoking Cessation
    • Prevention—pneumococcal & influenza vaccine

    CAP—Empiric Treatments

    • Outpatient: Azithromycin, Clarithromycin, Doxycycline
    • Inpatient, non-ICU: Levofloxacin, Moxifloxacin, Combination of a beta-lactam + macrolide
    • Inpatient, ICU: Combination of a beta-lactam + macrolide, Levofloxacin, Moxifloxacin

    CURB-65—Mortality Prediction Tool for Patients with CAP

    • Confusion
    • Urea >7 mmol/L
    • Respiratory rate ≥30/min
    • Blood pressure ≤90 mmHg
    • Age ≥65 years

    Chronic Cough

    • Lasting beyond 8 weeks
    • Most common causes: postnasal drip, GERD, Asthma
    • Differential diagnoses: Cigarette smoking, postnasal drip/allergies/chronic sinusitis, Bronchospasm/asthma, CHF, Bronchogenic/mediastinal tumors, Chronic pulmonary infections, etc.

    Bronchiectasis

    • Chronic cough
    • Overproduction of secretions
    • Reduced clearance of secretions
    • These result in excess airway secretions

    Chronic Cough—Evaluation

    • History: development, duration, character, precipitants
    • Environmental exposures
    • Tobacco use
    • History of asthma or COPD
    • Swallowing/throat clearing
    • GI symptoms
    • Physical Exam: ENT, Lungs, Cardiac, Abdomen
    • CXR: excludes malignant disease, bronchiectasis, persistent pneumonia, sarcoidosis, TB
    • Spirometry

    Diagnostics

    • CT chest with contrast
    • Spiral CT
    • Barium esophagography
    • Cardiac evaluation
    • Bronchoscopy
    • GI evaluation
    • Barium swallow and/or 24-hour pH esophageal monitoring
    • CT sinuses—ENT evaluation

    Treatment

    • Stop offending meds
    • Treat underlying cause
    • Consider trial of H2 blockers or PPI
    • Anti-tussives as indicated
    • Stop smoking

    Single Pulmonary Nodule

    • Common incidental finding on CT
    • Review with new algorithms for evaluation and management
    • Pure subsolid SPN < 5mm require no follow-up
    • If SPN < 8mm follow Fleischner Society guidelines on intervals for repeat CT
    • If SPN >8mm refer specialist

    Obstructive Sleep Apnea

    • Pause in breathing for 10–90 seconds
    • Central apneas: absent airflow and respiratory efforts
    • Neurological diseases
    • Obstructive apneas (OSA): Tongue and soft palate fall backward
    • Mixed apneas

    Consequences

    • Pulmonary HTN
    • HTN with LV Dysfunction
    • Cardiac dysrhythmias
    • Psychomotor defects
    • Hypoxia and hypercapnia

    Management

    • General measures: Avoidance of alcohol, sedatives, hypnotics
    • Specific measures: Position therapy, Positive airway pressure (CPAP, bilevel systems, auto-CPAP), Oral appliances, Surgical management

    Geriatric Specific Considerations

    • Age-related pulmonary changes: Reduced airway size, Shallow alveolar sacs, Decline in chest wall compliance, Intercostal muscle atrophy, Reduction in diaphragmatic strength by 25%

    Rhinosinusitis

    • Approaches to diagnosis, treatment do not differ with age
    • Treat bacterial rhinosinusitis with analgesics, saline irrigation, and antibiotics if symptoms ≥7 days or worsen
    • Treat chronic rhinosinusitis with topical nasal steroids and saline irrigation
    • Treat allergic rhinosinusitis by recommending avoidance of inciting allergens and/or with topical nasal steroids and anti-allergy medications

    Studying That Suits You

    Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

    Quiz Team

    Related Documents

    Description

    Learn about initiating and stepping down asthma treatment, including adjusting medication and finding the minimum effective dose to control symptoms and exacerbations.

    More Like This

    Asthma: Pathogenesis and Treatment
    17 questions

    Asthma: Pathogenesis and Treatment

    InvulnerableConnemara7993 avatar
    InvulnerableConnemara7993
    Pharmacology of Asthma Treatments
    44 questions
    Use Quizgecko on...
    Browser
    Browser